Related Experiment Video
Updated: Mar 17, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Current status of carotid ultrasound in atherosclerosis
1Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Insights
Cardiovascular disease risk prediction improves by assessing carotid plaque burden, not just intima-media thickness. Advanced ultrasound enhances detection of vulnerable plaques for better stroke risk assessment.
Area of Science:
- Cardiovascular imaging and atherosclerosis research.
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality, often driven by atherosclerosis.
- Sonographic carotid intima-media thickness (CIMT) is a common marker for subclinical atherosclerosis, but lacks standardized measurement, limiting its clinical utility.
- CIMT alone has limited predictive value for CVD; incorporating plaque presence significantly enhances prediction.
Purpose of the Study:
- To highlight the limitations of CIMT in CVD risk prediction.
- To emphasize the enhanced predictive power of carotid plaque assessment.
- To explore the role of advanced ultrasound in identifying high-risk plaques for stroke risk stratification.
Main Methods:
- Review of existing evidence on CIMT and carotid plaque characteristics in CVD risk prediction.
- Discussion of advances in ultrasound technology for plaque assessment.
- Analysis of the impact of plaque quantification and characterization on predictive power.
Main Results:
- Standardized CIMT measurement is lacking, leading to inconsistent findings.
- Carotid plaque presence improves CVD prediction over CIMT alone.
- Quantification of plaque burden and sonographic plaque characteristics further enhance predictive accuracy.
- Advanced ultrasound enables detection of high-risk/vulnerable plaques.
Conclusions:
- Carotid plaque assessment, including burden and characteristics, offers superior CVD and ischemic stroke risk prediction compared to CIMT alone.
- Advanced ultrasound technology facilitates comprehensive carotid plaque evaluation for improved patient risk stratification.
- Standardization of measurement methodologies remains crucial for maximizing the clinical value of carotid ultrasound in atherosclerosis management.
Abstract:
Cardiovascular disease (CVD) primarily caused by atherosclerosis is a major cause of death and disability in developed countries. Sonographic carotid intima-media thickness (CIMT) is widely studied as a surrogate marker for detecting subclinical atherosclerosis for risk prediction and disease progress to guide medical intervention. However, there is no standardized CIMT measurement methodology in clinical studies resulting in inconsistent findings, thereby undermining the clinical value of CIMT. Increasing evidences show that CIMT alone has weak predictive value for CVD while CIMT including plaque presence consistently improves the predictive power. Quantification of plaque burden further enhances the predictive power beyond plaque presence. Sonographic carotid plaque characteristics have been found to be predictive of cerebral ischaemic events. With advances in ultrasound technology, enhanced assessment of carotid plaques is feasible to detect high-risk/vulnerable plaques, and provide risk assessment for ischemic stroke beyond measurement of luminal stenosis.
More Related Videos
11:00A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
Published on: June 22, 2010
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Atherosclerosis III: Management